Neurosciences
ROCHESTER, Minn. — An international study led by Mayo Clinic researchers has identified interleukin-6 (IL-6) receptor blockers as a promising option for preventing relapses in[...]
Latest stories
Individualized Medicine
November 12, 2024
Cardiovascular
November 7, 2024
Research
November 7, 2024
Individualized Medicine
November 6, 2024
Individualized Medicine
November 5, 2024
Health & Wellness
October 31, 2024
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community